Zogenix, Astellas sales and marketing update

Zogenix and Astellas launched Sumavel DosePro sumatriptan in the U.S. for the acute treatment of migraine attacks with or without aura and for the acute treatment of cluster headache episodes. The wholesale acquisition cost (WAC) for the sumatriptan delivered subcutaneously via the DosePro needle-free system is $83 per 0.5 mL dose. Each 0.5 mL dose contains 6 mg sumatriptan. Astellas' Astellas Pharma U.S. Inc. unit co-promotes Sumavel DosePro with Zogenix in the U.S. Zogenix acquired Sumavel DosePro from Aradigm Corp. (OTCBB: ...